StockData
CERo Therapeutics Holdings, Inc. logo

CERo Therapeutics Holdings, Inc. (CERO) stock

CEROOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as CEROW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$0.01+0.00 (0.00%)

Close on Oct 19, 2026Market cap $253.05KP/E –Yield 172833.33%

What it earns on the capital it uses

Trailing twelve months over average capital

Return on assets-402.6%vs -40.7%

How hard the assets work

Profit per employee-$2.04Mvs -$704.12K

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it owes and what covers it

Latest balance sheet, against twelve months of cash generation

Leverage and liquidity

Current ratio0.05vs 3.30
Quick ratio0.03vs 2.39

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

How the shares have traded

Total return includes reinvested dividends, to the close on Oct 19, 2026

Total return against the S&P 500

The axis is compressed: each step is ten times the one before, so a month and a decade fit on the same line.

CEROS&P 500
PeriodCEROS&P 500DifferenceCERO per yearS&P 500 per year
1 month-41.2%+0.6%−41.8 pts
3 months-45.5%+3.4%−48.8 pts
Year to date-91.0%+13.3%−104.3 pts
1 year-99.7%+16.6%−116.3 pts
3 years-100.0%+86.4%−186.4 pts-99.3%+23.1%

Who is betting against it

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M CERO shares were sold short on Oct 30, 2026, up 1911.5% from the previous report. At recent volumes it would take 1.0 days to buy them back. Over the last 20 sessions, 65.5% of the volume reported to FINRA was short selling.

Shares sold shortDays to cover

The last twelve reports

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 202620,236+1911.5%922,0671.0
Oct 15, 20261,006-91.9%1,926,2071.0
Sep 30, 202612,363+397.5%666,1081.0
Sep 15, 20262,485-93.1%1,638,6081.0
Aug 31, 202636,072+3485.7%801,7221.0
Aug 14, 20261,006-95.2%861,7331.0
Jul 31, 202620,757+151.0%929,9021.0
Jul 15, 20268,271+24.8%1,717,3691.0
Jun 30, 20266,626+21.5%2,106,8481.0
Jun 15, 20265,452-84.7%2,724,7121.0
May 29, 202635,529+26.0%1,925,4291.0
May 15, 202628,198-75.0%776,4551.0

Every measure, in full

19 figures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Jun 30, 2026
Share price as of
–

Share statisticsIndustry

Float
37M
49M
Shares Held by Insiders
48.6%
11.2%
Shares Held by Institutions
0.00%
56.2%

Returns on capitalIndustry

Return on Assets (ROA)
-402.6%
-40.7%

Financial positionIndustry

Current Ratio
0.05
3.30
Quick Ratio
0.03
2.39

EfficiencyIndustry

Profits Per Employee
-$2.04M
-$704.12K
Employee Count
8
75

Income statement (TTM)Industry

Net Income
-$16.31M
-$22.47M

Balance sheetIndustry

Net Cash (Debt)
$862.76K
$15.35M
Net Cash Per Share
$0.01
$0.71
Equity (Book Value)
-$30.51M
$49.84M
Book Value Per Share
-$0.43
$1.45
Tangible Book Value
-$30.51M
$23.91M
Working Capital
-$30.86M
$74.41M

Dividends and yieldsIndustry

Dividend Per Share
$10.37
$0.83
Years of Dividend Growth
0
0

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?